Literature DB >> 1383428

Formation and clearance of interstitial metabolites of dopamine and serotonin in the rat striatum: an in vivo microdialysis study.

P Cumming1, E Brown, G Damsma, H Fibiger.   

Abstract

In vivo microdialysis was employed in order to characterize the steady-state kinetics of the turnover of specific dopamine and serotonin metabolites in the rat striatum 48 h after surgery. Inhibitors of monoamine oxidase (MAO; pargyline) and catechol-O-methyltransferase (COMT; Ro 40-7592) were administered, either separately or in conjunction, at doses sufficient to block these enzymes in the CNS. In some experiments, the acid metabolite carrier was blocked with probenecid. Temporal changes were then observed in the efflux of interstitial dopamine, 3-methoxytyramine (3-MT), 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), and 5-hydroxyindoleacetic acid (5-HIAA). The fractional rate constants for the accumulation or disappearance of the metabolites could be determined after pharmacological blockade of catabolic enzymes or the acid metabolite carrier. Interstitial 5-HIAA was found to be cleared with a half-life of approximately 2 h. After blockade of either MAO or COMT, HVA disappeared with a half-life of 17 min. Experiments employing probenecid suggested that some of the interstitial HVA was cleared by the acid metabolite carrier, the remainder being cleared by a probenecid-insensitive process, possibly conjugation. After MAO inhibition, DOPAC disappeared with an apparent half-life of 11.3 min. The rate of 3-MT accumulation after pargyline indicated that the majority of interstitial HVA (> 95%) is formed from DOPAC rather than 3-MT. The formation of 3-MT from interstitial dopamine, calculated from the accumulation rate of 3-MT after pargyline, appeared to follow first-order kinetics (k = 0.1 min-1).

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1383428     DOI: 10.1111/j.1471-4159.1992.tb11026.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

1.  Dopaminergic innervation of the rat globus pallidus characterized by microdialysis and immunohistochemistry.

Authors:  Holger Fuchs; Wolfgang Hauber
Journal:  Exp Brain Res       Date:  2003-09-24       Impact factor: 1.972

Review 2.  Effects of chronic neuroleptic treatment on dopamine release: insights from studies using 3-methoxytyramine.

Authors:  M F Egan; S Chrapusta; F Karoum; B K Lipska; R J Wyatt
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  Biopsychosocial influence on shoulder pain: Rationale and protocol for a pre-clinical trial.

Authors:  Steven Z George; Roland Staud; Paul A Borsa; Samuel S Wu; Margaret R Wallace; Warren H Greenfield; Lauren N Mackie; Roger B Fillingim
Journal:  Contemp Clin Trials       Date:  2017-03-14       Impact factor: 2.226

4.  Risperidone in ultra low dose protects against stress in the rodent cold restraint model by modulating stress pathways.

Authors:  Sairam Krishnamurthy; Debapriya Garabadu; Nagannathahalli Ranga Reddy; Keerikkattil P Joy
Journal:  Neurochem Res       Date:  2011-06-10       Impact factor: 3.996

5.  Short- and long-term effects of p-ethynylphenylalanine on brain serotonin levels.

Authors:  Luc Zimmer; André Luxen; Fabrice Giacomelli; Jean-François Pujol
Journal:  Neurochem Res       Date:  2002-04       Impact factor: 3.996

6.  In Vivo Ambient Serotonin Measurements at Carbon-Fiber Microelectrodes.

Authors:  Aya Abdalla; Christopher W Atcherley; Pavithra Pathirathna; Srimal Samaranayake; Beidi Qiang; Edsel Peña; Stephen L Morgan; Michael L Heien; Parastoo Hashemi
Journal:  Anal Chem       Date:  2017-09-07       Impact factor: 6.986

7.  Striatal metabolism of hexanal, a lipid peroxidation product, in the rat.

Authors:  V Jaar; L Ste-Marie; J A Montgomery
Journal:  Metab Brain Dis       Date:  1999-06       Impact factor: 3.584

8.  Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine.

Authors:  W A Cass; M W Manning
Journal:  J Neurosci       Date:  1999-09-01       Impact factor: 6.167

9.  The reward system and maternal behavior in an animal model of depression: a microdialysis study.

Authors:  Yael Lavi-Avnon; Aron Weller; John P M Finberg; Iris Gispan-Herman; Noa Kinor; Yaakov Stern; Mariana Schroeder; Vered Gelber; S Yoav Bergman; David H Overstreet; Gal Yadid
Journal:  Psychopharmacology (Berl)       Date:  2007-10-11       Impact factor: 4.530

10.  Citalopram protects against cold-restraint stress-induced activation of brain-derived neurotrophic factor and expression of nuclear factor kappa-light-chain-enhancer of activated B cells in rats.

Authors:  Debapriya Garabadu; B C M Harshavardhan Reddy; Sairam Krishnamurthy
Journal:  J Mol Neurosci       Date:  2014-06-01       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.